Scroll
To Top

Oct. 14, 2020

TOPIC: Featured News, Patients & Members, Research, Industry, RDCA-DAP

NORD and C-Path Release New Video, “RDCA-DAP: Shortening the Timeline for Developing New Treatments for Rare Diseases”

Posted by Laura Mullen

NORD and the Critical Path Institute (C-Path) are collaborating on a new initiative, the Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP), bringing together data from different sources, making it available for use and providing analytics tools to help researchers and drug developers overcome challenges in rare disease drug development. Watch video #3 in NORD and C-Path’s three-part video series, RDCA-DAP: Shortening the Timeline for Developing New Treatments for Rare Diseases,” which highlights the ways RDCA-DAP can help to streamline and speed the journey to rare disease cures and treatments throughout the five stages of the drug development process. You can watch the video or learn more about the RDCA-DAP here: https://rarediseases.org/rdca-dap/